Influence of 18F-PDG-PET on treatment in patients with differentiated thyroid cancer.

被引：0
|
作者：
Schlyter, B [1 ]
Plotkin, M [1 ]
Klutmann, S [1 ]
Beyer, W [1 ]
Bohuslavizki, H [1 ]
Mester, J [1 ]
Clausen, M [1 ]
机构：
[1] Univ Hamburg, Hosp Eppendorf, D-20246 Hamburg, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 1999年 / 40卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1041
引用
收藏
页码：234P / 234P
页数：1
相关论文
共 50 条
  • [41] 18F-Fluorodeoxyglucose Uptake in Metastases of Differentiated Thyroid Cancer: Does It Influence The Prognosis ?
    Menzel, C.
    Zaplatnikov, K.
    Doebert, N.
    Diehl, M.
    Hamscho, N.
    Kovacs, A.
    Gruenwald, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S28 - S29
  • [42] Utility of 18F-FDG-PET (PET) in the diagnosis of local recurrence or metastasis in follow-up of patients treated for Differentiated Thyroid Cancer
    Esteva-Fernandez, D.
    Muros, M. A.
    Bellon-Guardia, M.
    Cabello-Garcia, D.
    Macias-Mir, P.
    Lopez-Ruiz, J. M.
    Jimenez-Alonso, J.
    Llamas-Elvira, J. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S101 - S101
  • [43] Safety of denosumab in patients with refractory differentiated thyroid cancer and advanced medullary thyroid cancer.
    Wassermann, Johanna
    Mathy, Elise
    Lescaille, Geraldine
    Slim, Marine
    Buffet, Camille
    Saie, Clotilde
    Braik-Djellas, Yasmin
    Simon, Jean-Marc
    Menegaux, Fabrice
    Tresallet, Christophe
    Chami, Linda
    Lussey-Lepoutre, Charlotte
    Herve, Genevieve
    Bernier, Marie-Odile
    Spano, Jean-Philippe
    Leenhardt, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] Clinical and pathological factors related to 18F-FDG-PET (PET) positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer (DTC)
    Muros, M. A.
    Esteva-Fernandez, D.
    Gallego, M.
    Santiago-Chinchilla, A.
    Muros, T.
    Torres-Vela, E.
    Lopez-Ruiz, J. M.
    Ramirez, A.
    Llamas-Elvira, J. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S374 - S374
  • [45] The predicting value of 18F-FDG PET/CT imaging of radioactive iodine treatment efficacy in patients with bone metastasis from differentiated thyroid cancer
    Wang, D.
    Ma, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S885 - S885
  • [46] Comparison of 18F-fluoride PET/CT, 18F-FDG PET/CT, and bone scintigraphy in detection of bone metastases of differentiated thyroid cancer
    Ota, N.
    Kato, K.
    Iwano, S.
    Ito, S.
    Tsuchiya, K.
    Okochi, Y.
    Okada, Y.
    Naganawa, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S383 - S383
  • [47] Influence of F-18FDG PET-CT fusion on radiotherapy treatment planning for head and neck cancer.
    Koshy, M
    Paulino, AC
    Howell, R
    Schuster, D
    Halkar, R
    Davis, L
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 496S - 496S
  • [48] Comparison of 18F-fluoride PET/CT, 18F-FDG PET/CT and 131I radioiodine diagnostic scan in patients of differentiated thyroid carcinoma with skeletal metastases: evaluation of the role of 18F-FDG PET/CT in bony metastatic disease from differentiated thyroid cancer
    Parghane, R. V.
    Basu, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S392 - S393
  • [49] Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
    Ito, S.
    Kato, K.
    Iwano, S.
    Ishigaki, T.
    Ikeda, M.
    Tadokoro, M.
    Makino, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S250 - S250
  • [50] Locoregional recurrence of differentiated thyroid cancer.
    ConteDevolx, B
    DiCostanzo, V
    Denizot, A
    Niccoli, P
    Henry, JF
    ANNALES D ENDOCRINOLOGIE, 1997, 58 (03) : 240 - 241
12345